Astrocyte-derived ciliary neurotrophic factor (CNTF) promotes adult subventricular zone (SVZ) neurogenesis. We found that focal adhesion kinase (FAK) and JNK, but not ERK or P38, repress CNTF in vitro. Here, we defined the FAK-JNK pathway and its regulation of CNTF in mice, and the related leukemia inhibitory factor (LIF) and interleukin-6 (IL-6), which promote stem cell renewal at the expense of neurogenesis. Intrastriatal injection of FAK inhibitor, FAK14, in adult male C57BL/6 mice reduced pJNK and increased CNTF expression in the SVZ-containing periventricular region. Injection of a JNK inhibitor increased CNTF without affecting LIF and IL-6, and increased SVZ proliferation and neuroblast formation. The JNK inhibitor had no effect in CNTF−/− mice, suggesting that JNK inhibits SVZ neurogenesis by repressing CNTF. Inducible deletion of FAK in astrocytes increased SVZ CNTF and neurogenesis, but not LIF and IL-6. Intrastriatal injection of inhibitors suggested that P38 reduces LIF and IL-6 expression, whereas ERK induces CNTF and LIF. Intrastriatal FAK inhibition increased LIF, possibly through ERK, and IL-6 through another pathway that does not involve P38. Systemic injection of FAK14 also inhibited JNK while increasing CNTF, but did not affect P38 and ERK activation, or LIF and IL-6 expression. Importantly, systemic FAK14 increased SVZ neurogenesis in wild-type C57BL/6 and CNTF+/+ mice, but not in CNTF−/− littermates, indicating that it acts by upregulating CNTF. These data show a surprising differential regulation of related cytokines and identify the FAK-JNK-CNTF pathway as a specific target in astrocytes to promote neurogenesis and possibly neuroprotection in neurological disorders.
bioavailability and serious side effects of systemic administration of CNTF protein (Thoenen & Sendtner, 2002) . We previously identified a novel inhibitory pathway consisting of integrins and downstream focal adhesion kinase (FAK) and c-Jun N-terminal kinase (JNK) using cultured C6 astroglioma cells (Keasey, Kang, Lovins, & Hagg, 2013) . Pharmacological inhibition of FAK or JNK induced CNTF in vitro. In mice, intrastriatal or systemic FAK inhibition increased CNTF and SVZ neurogenesis. Integrin receptors also can activate other mitogen-activated protein kinase (MAP) kinases through FAK, including extracellular signal-regulated kinase (ERK) and p38 MAP kinase (Giancotti & Ruoslahti, 1999; Hunter & Eckhart, 2004; Staquicini et al., 2009 ). To identify pharmacological targets that might be more selective than FAK, we here determined the roles of JNK, P38, and ERK in regulating CNTF and neurogenesis in the adult mouse SVZ.
CNTF belongs to a cytokine family that activates the gp130 receptor, including leukemia inhibitory factor (LIF) and interleukin-6 (IL-6) (Zigmond, 2011) . LIF promotes stem cell self-renewal (Gregg & Weiss, 2005; Pitman et al., 2004; Shimazaki, Shingo, & Weiss, 2001) at the expense of neuroblast formation (neurogenesis) in the SVZ (Bauer & Patterson, 2006) . IL-6 inhibits progenitor proliferation and neuronal differentiation (Bowen, Dempsey, & Vemuganti, 2011; Covey, Loporchio, Buono, & Levison, 2011) . LIF and IL-6 seem to initially inhibit the CNTF-mediated increase in neurogenesis that occurs after an ischemic stroke in mice . The mechanisms that regulate LIF and IL-6 in the SVZ are unknown. Identifying such intracellular signaling pathways may help to therapeutically modulate their expression in the CNS in disorders characterized by excessive inflammation. Our previous study showed that FAK inhibition reduced LIF and IL-6 expression in cultured C6 cells (Keasey et al., 2018) . Here, we determined whether JNK, P38, and ERK downstream from FAK might regulate LIF and IL-6.
| MATERIALS AND METHODS

| Animals
A total of 243 mice were used. Adult male C57BL/6 (8-10 weeks old, JAX Stock 000664) were purchased from Jackson Laboratory. Heterozygous CNTF knockout mice (Emsley & Hagg, 2003; Kang et al., 2013; Valenzuela et al., 2003; Yang et al., 2008) were bred to produce F1 sex-matched littermates for experiments. CNTF breeders were originally obtained from Regeneron Pharmaceuticals and were on a C57BL/6 × 129Sv background. We have backcrossed them seven times into the JAX C57BL/6 line. In these mice, a lacZ gene was inserted in the deleted CNTF locus so that CNTF expression can be indirectly assessed by β-galactosidase protein expression (Kang et al., 2012; Valenzuela et al., 2003; Yang et al., 2008) . We use heterozygous CNTF+/− mice for such reporter studies to retain CNTF expression. They respond to stroke, which promotes neurogenesis through CNTF, in the same way as the wild-type CNTF+/+ mice . Mice with floxed alleles of FAK (B6;129X1-Ptk2 sunflower oil (20 mg/ml) at 37 C overnight and stored at 4 C in the dark for up to 7 days (Kim et al., 2014 BrdU was given for 3 days and these mice processed for histology.
Intrastriatal injections were performed as previously described Kang et al. (2012) . Briefly, anesthetized mice were mounted into a Kopf stereotaxic apparatus with two ear bars and a tooth bar set at 0 mm. A burr hole was drilled at coordinates +1-mm rostrocaudal and 1. Hagimoto, Takami, Murakami, & Tanabe, 2017) overnight at 4 C as described previously (Jia & Hegg, 2015 
| Cell counts
Every sixth 30 μm thick coronal section stained for BrdU through the SVZ along the rostrocaudal axis was used to perform unbiased and stereological analysis of BrdU-positive nuclei in the SVZ (total six sections per brain). The analysis was performed blinded to the treatments as described previously in Baker, Baker, and Hagg (2004) and Kang et al. (2013) using an optical fractionator stereological method (Stereologer, System Planning and Analysis, Alexandria, VA) and a motorized Leica DMIRE2 microscope. The reference space for the SVZ was defined as a 50-μm wide strip of the entire lateral wall of lateral ventricle, and, in the rostrocaudal axis, from the genu of the corpus callosum up to the decussation of the anterior commissure (Baker et al., 2004; Baker, Baker, & Hagg., 2005) . For the pulse-chase study, 
| Western blotting
The SVZ was homogenized by sonication in 100 μl RIPA buffer supplemented with protease and phosphatase inhibitors. The concentration of protein in the homogenate was measured using a bicinchoninic acid (BCA) protein assay kit (Thermo Scientific, 
| RT-qPCR
RT-qPCR was performed as described previously .
Briefly, total RNA from SVZ was isolated using RNeasy Mini Kit 
| Statistical analyses
Data are presented as mean AE SEM. Statistical analyses were performed using GraphPad Prism (version 7). A value of p ≤ .05 was considered to be statistically significant. A one-way analysis of variance (ANOVA) with Bonferroni post hoc multiple comparisons was applied when there were three or more groups with testing for one factor. A two-way ANOVA with post hoc Tukey multiple comparisons was used when the groups were four or more and there were two factors to be tested, such as genotypes and treatments. If only two groups were compared, a Student's t test was used.
3 | RESULTS 3.1 | Intracerebral FAK inhibition reduces JNK activation which increases neurogenesis in the adult mouse SVZ through CNTF
We previously showed that FAK and JNK repress CNTF expression in astroglioma C6 cells . Here, male C57BL/6 mice were injected with the FAK inhibitor FAK14 into the striatum vs. 27,608 AE 3,859 total, and 85 AE 10 vs. 73 AE 9 per section, respectively). This suggests that the lack of a response to the JNK inhibitor treatment in the CNTF−/− mice was not due to different baseline levels of neurogenesis. Taken together, these data indicate that JNK plays an important and very specific role in regulating SVZ neurogenesis exclusively via repressing CNTF.
| Astrocyte-specific genetic deletion of FAK increases CNTF and neurogenesis
To confirm the role of astrocytic FAK in inhibiting CNTF expression in the SVZ and periventricular region, we generated mice with tamoxifeninducible conditional deletion of FAK in GFAP-positive astrocytes (Mori et al., 2006) . The GFAP-cre-mediated deletion of FAK in the periventri- Figure S1 ). This suggests that the results from the injection experiments closely 
| Systemic FAK inhibitor treatment selectively inhibits JNK and increases CNTF
We had previously shown that systemic injection of FAK14 stimulated CNTF expression and SVZ neurogenesis . Therefore, we determined whether systemic FAK14 treatment would affect Figure 1f ), LIF and IL-6 mRNA expression in the periventricular region (note the different scale for the IL-6 values; student t test, *, **, *** or **** p < .05, .01, .001, or .0001, respectively) FIGURE 6 Intrastriatal P38 inhibition increases LIF and IL-6 expression without affecting neurogenesis in the adult mouse SVZ. Intrastriatal injection of the P38 inhibitor, SB203580, reduced phosphorylation of P38 in the periventricular region of adult C57BL/6 mice at 24 h compared with injection of control vehicle, as shown by reduced pP38 in a representative western blot of individual mice (a) and densitometry quantification (b, n = 9, 5, and 5 mice, one-way ANOVA followed by Bonferroni multiple comparison tests, * p < .05). (c) In the same mice, P38 inhibition increased LIF and IL-6 expression at 24 h, without altering CNTF, in the periventricular region (student t test, * or ** p < .05 or .01). Although the difference was not statistically significant, it is possible that the efficiency of the FAK inhibitor is greater than the cre-lox
recombination.
Finally, we tested whether FAK14-induced CNTF might regulate neurogenesis by affecting slowly proliferating neural stem cells in the SVZ, by using a BrdU pulse-chase method. CNTF+/+ and CNTF−/− mice were injected daily for 3 days with PBS or FAK14 followed 4 h later by BrdU. This was followed by a 20-day wash-out period to allow BrdUincorporated neuroblasts to migrate away from the SVZ. The BrdUretaining cells in the SVZ represent slowly proliferating cells, such as stem cells, and post-mitotic cells (Doetsch et al., 1999; Hsu, 2015) . 
| DISCUSSION
The main findings of this study are (a) the unique role of FAK-JNK signaling, compared with other MAPKs, in repressing CNTF expression and neurogenesis in the SVZ of adult mice, (b) the surprising differential signaling pathways that regulate the highly related cytokines LIF and IL-6, and (c) the specific role of FAK in the astrocyte in the production of these cytokines which play key roles in regulating SVZ neurogenesis.
| FAK-JNK pathway inhibition uniquely increases CNTF expression in the SVZ
Intratriatal FAK inhibition with FAK14 increased CNTF expression in the SVZ, as previously seen with PF573228 (Keasey et al., 2013), another specific FAK inhibitor (Keasey et al., 2018) . Intrastriatal FAK14 decreased JNK but increased P38 and ERK activation, suggesting some specificity of pathway regulation downstream of FAK. Moreover, intrastriatal JNK, but not P38 or ERK inhibition increased CNTF expression, consistent with C6 astroglioma cells .
The finding that systemic FAK14 increases CNTF expression but only affected pJNK and not P38 or ERK, also supports the specific role of JNK ( Figure 10 ). FAK-JNK-mediated repression of CNTF is unique compared with other cytokines, since intrastriatal JNK inhibition or systemic FAK14 did not affect LIF and IL-6 expression. The different effects of intrastriatal and systemic FAK inhibition on P38, ERK, and the related expression of LIF and IL-6 is potentially due to differential access of FAK14 to different cell types or cell structures. In the SVZ, CNTF is expressed by astrocytes that form densely packed end-feet around the microvasculature (Shen et al., 2008; Tavazoie et al., 2008; Yang et al., 2008) . Thus, whereas intrastriatal FAK14 has access to astrocytes, microglia and neurons which all can produce LIF and IL-6 (Banner, Moayeri, & Patterson, 1997; Erta, Quintana, & Hidalgo, 2012; Lau & Yu, 2001; Schlaepfer et al., 2007; Van Wagoner, Oh, Repovic, & Benveniste, 1999) , systemic injection may primarily deliver FAK14 to astrocytes through their end-feet.
The unique role of astrocytic FAK in regulating SVZ CNTF is supported by the inducible conditional astrocyte-FAK knockout mice. LIF and IL-6 were not affected in these mice, suggesting that intrastriatal FAK14 increased their expression in cell types which remain to be . STAT3 may play a dual role because CNTF transcription is stimulated through the gp130-JAK-STAT3 pathway, involving pY705-STAT3 (Kang et al., 2012; Keasey et al., 2013; Shuto et al., 2001 ). Integrin-FAK-S727-STAT3 signaling also promotes mitochondrial function (Boengler, Hilfiker-Kleiner, Heusch, & Schulz, 2010; Boengler, Ungefug, Heusch, & Schulz, 2013; Szczepanek et al., 2011; Visavadiya et al., 2016; Wegrzyn et al., 2009 ).
FAK-mediated integrin signaling maintains normal blood brain barrier function (del Zoppo & Milner, 2006) . It remains to be determined Our data suggest that promoting neurogenesis requires increased CNTF without concomitant increases in LIF and/or IL-6, which are known to reduce neuroblast formation by promoting stem cell selfrenewal (Bauer & Patterson, 2006; Bowen et al., 2011; Covey et al., 2011; Gregg & Weiss, 2005; Pitman et al., 2004; Shimazaki et al., 2001 ). Thus, the P38 inhibitor, which increased LIF and IL-6, but not CNTF, did not increase neurogenesis. In contrast, systemic FAK14, intrastriatal JNK inhibitor and astrocytic knockout of FAK increased CNTF and promoted neurogenesis, but did not affect LIF or IL-6. This is consistent with CNTF-mediated increased neurogenesis after stroke only when IL-6 expression drops to normal levels .
The current pulse-chase experiment suggests that acute induction of CNTF by FAK14 did not affect neural stem cell proliferation. This indicates that FAK14-increased CNTF acts on progenitor cells, possibly through FGF2, as we have proposed .
The pulse-chase BrdU data from CNTF−/− mice also suggest that chronic basal levels of CNTF promote neural stem cell proliferation in the SVZ. These cells can respond to CNTF because CNTFα receptors in the SVZ are exclusively expressed in GFAP-positive cells (Emsley & Hagg, 2003) , including the much sparser neural stem cells (Doetsch et al., 1999; Emsley & Hagg, 2003; Ponti, Obernier, & Alvarez-Buylla, 2013a; Ponti, Obernier, Guinto, et al., 2013b) . In fact, CNTF together with EGF stimulates SVZ neural stem cell self-renewal through upregulation of notch 1 in vitro and in vivo (Chojnacki, Shimazaki, Gregg, Weinmaster, & Weiss, 2003) . It remains to be determined how longterm FAK and JNK inhibitor treatments that induce CNTF would affect neural stem cells.
| P38 and ERK signaling differentially regulates CNTF, LIF and IL-6
Integrin signaling is known to activate FAK and downstream JNK, ERK and P38 MAP kinases (Giancotti & Ruoslahti, 1999; Hunter & Eckhart, 2004; Staquicini et al., 2009) . Surprisingly, there were substantial differential effects of inhibiting these MAPKs on the expression of the highly related CNTF, LIF, and IL-6. P38 inhibition increased LIF and IL-6, but not CNTF, while ERK inhibition reduced CNTF and LIF, but not IL-6 (Figure 10 ). LIF expression in Schwann cells is increased by the cAMP-PKCβ-ERK pathway (Matsuoka, Nakane, & Kurihara, 1997; Nagamoto-Combs, Vaccariello, & Zigmond, 1999) and cAMP induces it in cultured astrocytes (Murphy Jr. et al., 1995) . However, ERK increases both LIF and CNTF ( Figure 10 ) and cAMP decreases CNTF expression in the SVZ (Yang et al., 2008) , suggesting redundant signaling pathways involved in fine-tuning cytokine expression in the SVZ.
The finding that intrastriatal FAK inhibition increases LIF would be most consistent with its activation of ERK, rather than disinhibiting P38 ( Figure 10 ). The opposing effects of P38 and ERK on LIF expression in the mouse periventricular region is consistent with their opposing effects on cultured neural stem cell proliferation (Kim & Wong, 2009) . Also, P38 inhibition can rescue their proliferation in the SVZ of ATM−/− mice (Kim & Wong, 2012) . P38 and ERK also have different roles on oligodendrocyte progenitor differentiation (Cui, Fang, Kennedy, Almazan, & Antel, 2014) , and both ERK and P38 are required for progenitor to preoligodendrocyte differentiation, but only P38 is involved in immature oligodendrocyte differentiation. Here, intracerebral P38 inhibition did not affect neurogenesis after 48 h, despite induction of LIF and IL-6, perhaps because the effects on the neural stem cells require longer times to subsequently affect progenitor proliferation. CNTF and IL-6 expression is downstream of STAT3 signaling Shuto et al., 2001; Sumimoto, Imabayashi, Iwata, & Kawakami, 2006) , suggesting that JNK, P38, and ERK are coregulators, consistent with their known role in STAT3 phosphorylation. However, it remains to be determined how the differential signaling occurs. The finding that intrastriatal FAK inhibition increases IL-6 expression is in apparent disagreement with a previous report that FAK mediates TNFα-induced IL-6 expression in cultured cancer cells and fibroblasts (Schlaepfer et al., 2007) . Moreover, FAK inhibition also down-regulates IL-6 in C6 cells (Keasey et al., 2018) . This raises the possibility that there are major differences between proliferating and non-proliferating cells. In fact, systemic FAK inhibition reduces strokeinduced IL-6 expression in adult mice (unpublished data), which would be consistent with the proliferating astrocytes and microglia. The finding that intrastriatal FAK inhibitor stimulates IL-6 expression and activates P38, whereas the P38 inhibitor also increased IL-6 expression, suggests that there is another IL-6 inhibiting pathway(s) downstream from FAK (stippled line in Figure 10 ).
| CONCLUSION
Collectively, these results indicate that CNTF plays a key role in promoting SVZ neurogenesis and is uniquely regulated by FAK-JNK signaling in astrocytes. JNK inhibition represents a novel method for promoting adult SVZ neurogenesis. Our data also reveal differential regulation mechanisms that may provide opportunities to individually regulate these cytokines in glial cells as a potential therapeutic approach for a variety of neurological disorders such as stroke, by increasing neurogenesis as well as neuronal and glial protection, and/or reducing excessive detrimental inflammation.
